Levy-Lahad E - Search Results

1

Cancer risks among BRCA1 and BRCA2 mutation carriers.

Levy-Lahad E, Friedman E. Levy-Lahad E, et al. Br J Cancer. 2007 Jan 15;96(1):11-5. doi: 10.1038/sj.bjc.6603535. Br J Cancer. 2007. PMID: 17213823 Free PMC article. Review.

2

The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.

Kreiss Y, Barak F, Baruch RG, Levy-Lahad E, Pras E, Friedman E. Kreiss Y, et al. Genet Test. 2000;4(4):403-7. doi: 10.1089/109065700750065171. Genet Test. 2000. PMID: 11216667

3

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.

Wolf I, Laitman Y, Rubinek T, Abramovitz L, Novikov I, Beeri R, Kuro-O M, Koeffler HP, Catane R, Freedman LS, Levy-Lahad E, Karlan BY, Friedman E, Kaufman B. Wolf I, et al. Oncogene. 2010 Jan 7;29(1):26-33. doi: 10.1038/onc.2009.301. Epub 2009 Oct 5. Oncogene. 2010. PMID: 19802015

4

Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.

Friedman E, Bar-Sade Bruchim R, Kruglikova A, Risel S, Levy-Lahad E, Halle D, Bar-On E, Gershoni-Baruch R, Dagan E, Kepten I, Peretz T, Lerer I, Wienberg N, Shushan A, Abeliovich AD. Friedman E, et al. Am J Hum Genet. 1998 Oct;63(4):1224-7. doi: 10.1086/302040. Am J Hum Genet. 1998. PMID: 9758598 Free PMC article. No abstract available.

5

BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.

Levy-Lahad E, Krieger M, Gottfeld O, Renbaum P, Klein G, Eisenberg S, Lahad A, Kaufman B, Catane R. Levy-Lahad E, et al. J Cell Biochem Suppl. 2000;34:13-8. J Cell Biochem Suppl. 2000. PMID: 10762009 Review.

6

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.

Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R. Levy-Lahad E, et al. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3232-6. doi: 10.1073/pnas.051624098. Proc Natl Acad Sci U S A. 2001. PMID: 11248061 Free PMC article.

7

High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.

Beller U, Halle D, Catane R, Kaufman B, Hornreich G, Levy-Lahad E. Beller U, et al. Gynecol Oncol. 1997 Nov;67(2):123-6. doi: 10.1006/gyno.1997.4844. Gynecol Oncol. 1997. PMID: 9367693

8

Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews.

Lieberman S, Chen-Shtoyerman R, Levi Z, Shkedi-Rafid S, Zuckerman S, Bernstein-Molho R, Levi GR, Shachar SS, Flugelman A, Libman V, Kedar I, Naftaly-Nathan S, Lagovsky I, Peretz T, Karminsky N, Carmi S, Levy-Lahad E, Goldberg Y. Lieberman S, et al. Among authors: levy lahad e. Breast Cancer Res Treat. 2022 May;193(1):217-224. doi: 10.1007/s10549-022-06557-9. Epub 2022 Mar 12. Breast Cancer Res Treat. 2022. PMID: 35278150

9

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D. Levy-Lahad E, et al. Am J Hum Genet. 1997 May;60(5):1059-67. Am J Hum Genet. 1997. PMID: 9150153 Free PMC article.

10

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

Hornreich G, Beller U, Lavie O, Renbaum P, Cohen Y, Levy-Lahad E. Hornreich G, et al. Gynecol Oncol. 1999 Nov;75(2):300-4. doi: 10.1006/gyno.1999.5568. Gynecol Oncol. 1999. PMID: 10525392 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page